An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Clinical trial NCT07033026 · RECRUITING
Trial details
- NCT number
- NCT07033026
- Sponsor
- NGM Biopharmaceuticals, Inc
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2027-04-01
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.